Here’s what you should know:
1. The companies expect the test will be available in 2020.
2. The tests detect polyp and carcinogenesis warning signs in the colon.
3. Prescient Medicine CEO and Founder Keri Donaldson said, “These simple yet incredibly powerful tools will dramatically change the equation when it comes to earlier identification of precancerous conditions, leading to early treatment decisions, reduced costs and better outcomes. Metabiomics is an extraordinary partner in our mission to prevent disease and provide the very best care at the lowest possible cost to the healthcare system.”
More articles on gastroenterology:
Envision loses another contract over out-of-network billing & more — 11 ASC company key notes
Total charges for top 10 procedures performed at ASCs in the Northeast
10 strategies to streamline ASC supply chain management
